146 related articles for article (PubMed ID: 24582932)
41. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
42. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.
Shi M; Shoichet MS
J Biomater Sci Polym Ed; 2008; 19(9):1143-57. PubMed ID: 18727857
[TBL] [Abstract][Full Text] [Related]
43. Amphiphilic comb-like polymers based on poly(oxyethylene)s as drug-delivery carriers.
Kim KH; Lee JC; Lee J
Macromol Biosci; 2008 Apr; 8(4):339-46. PubMed ID: 18098266
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.
Akagi T; Kaneko T; Kida T; Akashi M
J Control Release; 2005 Nov; 108(2-3):226-36. PubMed ID: 16125267
[TBL] [Abstract][Full Text] [Related]
45. Molecular weight controls the elongation of oblate-shaped degradable poly(γ-benzyl-L-glutamate)nanoparticles.
Cauchois O; Segura-Sanchez F; Ponchel G
Int J Pharm; 2013 Aug; 452(1-2):292-9. PubMed ID: 23665007
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of an amphiphilic poly(gamma-glutamic acid)-cholesterol conjugate and its application as an artificial chaperone.
Lee EH; Kamigaito Y; Tsujimoto T; Uyama H; Sung MH
J Microbiol Biotechnol; 2010 Oct; 20(10):1424-9. PubMed ID: 21030827
[TBL] [Abstract][Full Text] [Related]
47. Intermolecular interaction and morphology investigation of drug loaded ABA-triblock copolymers with different hydrophilic/lipophilic ratios.
Khoee S; Rahimi HB
Bioorg Med Chem; 2010 Oct; 18(20):7283-90. PubMed ID: 20833053
[TBL] [Abstract][Full Text] [Related]
48. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
49. Block copolypeptide nanoparticles for the delivery of ocular therapeutics.
Stukenkemper T; Dose A; Caballo Gonzalez M; Groenen AJ; Hehir S; Andrés-Guerrero V; Herrero Vanrell R; Cameron NR
Macromol Biosci; 2015 Jan; 15(1):138-45. PubMed ID: 25521091
[TBL] [Abstract][Full Text] [Related]
50. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
[TBL] [Abstract][Full Text] [Related]
51. Double smectic self-assembly in block copolypeptide complexes.
Haataja JS; Houbenov N; Iatrou H; Hadjichristidis N; Karatzas A; Faul CF; Rannou P; Ikkala O
Biomacromolecules; 2012 Nov; 13(11):3572-80. PubMed ID: 22970916
[TBL] [Abstract][Full Text] [Related]
52. Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles.
Li Y; Qian Y; Liu T; Zhang G; Liu S
Biomacromolecules; 2012 Nov; 13(11):3877-86. PubMed ID: 23013152
[TBL] [Abstract][Full Text] [Related]
53. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
54. Characterization and analytical development for amphiphilic poly(γ-glutamic acid) as raw material of nanoparticle adjuvants.
Ikeda M; Akagi T; Yasuoka T; Nagao M; Akashi M
J Pharm Biomed Anal; 2018 Feb; 150():460-468. PubMed ID: 29294451
[TBL] [Abstract][Full Text] [Related]
55. Hybrid protein-synthetic polymer nanoparticles for drug delivery.
Koseva NS; Rydz J; Stoyanova EV; Mitova VA
Adv Protein Chem Struct Biol; 2015; 98():93-119. PubMed ID: 25819277
[TBL] [Abstract][Full Text] [Related]
56. Poly(L-glutamic acid)-decorated hybrid colloidal particles from complex particle-templated silica mineralization.
Shiu CC; Wang S; Chang CH; Jan JS
J Phys Chem B; 2013 Aug; 117(34):10007-16. PubMed ID: 23822799
[TBL] [Abstract][Full Text] [Related]
57. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
58. Linear polymers of β and γ cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin.
Oliveri V; Bellia F; Viale M; Maric I; Vecchio G
Carbohydr Polym; 2017 Dec; 177():355-360. PubMed ID: 28962779
[TBL] [Abstract][Full Text] [Related]
59. Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model.
Cırpanlı Y; Allard E; Passirani C; Bilensoy E; Lemaire L; Calış S; Benoit JP
Int J Pharm; 2011 Jan; 403(1-2):201-6. PubMed ID: 20951783
[TBL] [Abstract][Full Text] [Related]
60. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]